The administration process involves several steps: 1. Leukapheresis: Collection of T cells from the patient's blood. 2. Genetic Modification: Laboratory alteration of T cells to express the CAR. 3. Expansion: Growing the modified T cells to sufficient numbers. 4. Conditioning Therapy: Chemotherapy to reduce the patient’s immune cells and improve the efficacy of the CAR T cells. 5. Infusion: Reintroducing the modified T cells back into the patient’s bloodstream.
